Skip to menu Skip to content Skip to footer
Dr Fernanda Cardoso
Dr

Fernanda Cardoso

Email: 
Phone: 
+61 7 344 33402

Overview

Background

Dr Fernanda Cardoso is a Brazil-born Australian dual-citizen researcher interested in venom peptide-based biodiscovery and therapeutics development. Cardoso was awarded an MSc in Molecular Pharmacology and a PhD with an emphasis in Biochemistry and Immunology and is part of the Institute for Molecular Bioscience, where she develops novel therapies for complex neurological diseases. Cardoso has interdisciplinary training in the fields of neuropharmacology, medicinal chemistry and chemical biology and a strong background in drug discovery, which provides the skills to identify naturally occurring or synthetic bioactive molecules and to study their effects in human physiology with applications in neurologic disorders such as chronic pain, irritable bowel syndrome (IBS), and motor neuron disease (MND). Please see Dr Cardoso’s Grants and Publications list for more details.

Before joining the University of Queensland, Dr Cardoso was part of the Queensland Institute for Medical Research, holding a prestigious CAPES Postdoctoral Fellowship. During this period, Cardoso developed unique high-throughput screen platforms for discovering protein and peptide targets of novel therapies to combat infectious diseases and novel helminth-derived bioactives with anti-inflammatory properties. Please see Dr Cardoso’s Publications list for more details.

Dr Cardoso is currently part of the Centre for Drug Discovery and manages several industry and academic projects studying ion channel modulators derived from natural repertoires, particularly venoms, and developing novel, effective drugs to treat neurological disorders.

Availability

Dr Fernanda Cardoso is:
Available for supervision
Media expert

Qualifications

  • Bachelor, Universidade Federal de Minas Gerais (UFMG)
  • Masters (Research) of Biological Sciences, Universidade Federal de Minas Gerais (UFMG)
  • Doctor of Philosophy, Universidade Federal de Minas Gerais (UFMG)

Research interests

  • Chronic pain - Pathophysiologcal mechanisms and Therapeutics development, Visceral Pain, Irritable Bowel Syndrome

  • Neurodegeneration - Pathophysiologcal mechanisms and Therapeutics development

  • Venomics and Pharmacology of Spiders, Cone snails and Snake venoms

  • Structure-function properties of venom peptides and proteins

  • Voltage-gated Ion Channels

Research impacts

Dr. Fernanda Cardoso's research has provided remarkable insights into the discovery and biology of new agents for therapeutical use in complex disorders such as chronic pain, irritable bowel syndrome and motor neuron disease, and vaccinology against tropical diseases. Her ongoing research in ion channel modulators has provided unique leads for treating neuropathic pain and neurodegenerative disorders, which could improve the lives of millions of individuals around the globe, and her past discoveries in vaccine research have the potential to improve the lives of millions of people in Africa, Asia and South America through a vaccine against schistosomiasis.

Works

Search Professor Fernanda Cardoso’s works on UQ eSpace

130 works between 2003 and 2025

41 - 60 of 130 works

2022

Conference Publication

High-throughput bioassays applied to phylogenetic and envenomation studies of spider and snake venoms

Cardoso, Fernanda C. (2022). High-throughput bioassays applied to phylogenetic and envenomation studies of spider and snake venoms. Venom Week VIII, Scottsdale, AZ, United States, 18-21 July 2022.

High-throughput bioassays applied to phylogenetic and envenomation studies of spider and snake venoms

2022

Conference Publication

The unexplored pharmacopeia of Australian spider venoms: learning from the experts

Wirth, Hayden and Cardoso, Fernanda C. (2022). The unexplored pharmacopeia of Australian spider venoms: learning from the experts. Pathogens and Natural Toxins e-Conference section Venomous Animals, Brisbane, Australia, 1 July - 31 August 2022.

The unexplored pharmacopeia of Australian spider venoms: learning from the experts

2022

Conference Publication

Idiosyncratic treatment of motor neuron disease: selective inhibition of voltage-gated sodium channels using spider venom peptide (ProTX-III) to treat motor neuron disease

Kotapati, Charan , Bellingham, Mark C. and Cardoso, Fernanda C. (2022). Idiosyncratic treatment of motor neuron disease: selective inhibition of voltage-gated sodium channels using spider venom peptide (ProTX-III) to treat motor neuron disease. Pathogens and Natural Toxins e-Conference section Diagnostics and Therapeutics From Natural Toxins, Brisbane, Australia, 1 July - 31 August 2022.

Idiosyncratic treatment of motor neuron disease: selective inhibition of voltage-gated sodium channels using spider venom peptide (ProTX-III) to treat motor neuron disease

2022

Conference Publication

Structure, function, and evolution of nettle caterpillar venom toxins

Goudarzi, Mohaddeseh H., Robinson, Samuel D., Cardoso, Fernanda C., Lawrence, Nicole, Chin, Yanni, King, Glenn F. and Walker, Andrew A. (2022). Structure, function, and evolution of nettle caterpillar venom toxins. Pathogens and Natural Toxins e-Conference, Brisbane, QLD Australia, 1 July - 31 August 2022.

Structure, function, and evolution of nettle caterpillar venom toxins

2022

Journal Article

Venom peptides: a rich combinatorial library for drug development

Cardoso, Fernanda C., Servent, Denis and de Lima, Maria Elena (2022). Venom peptides: a rich combinatorial library for drug development. Frontiers in Molecular Biosciences, 9 924023, 924023. doi: 10.3389/fmolb.2022.924023

Venom peptides: a rich combinatorial library for drug development

2022

Journal Article

Inhibition of N-type calcium ion channels by tricyclic antidepressants – experimental and theoretical justification for their use for neuropathic pain

Cardoso, Fernanda C., Schmit, Matthieu, Kuiper, Michael J., Lewis, Richard J., Tuck, Kellie L. and Duggan, Peter J. (2022). Inhibition of N-type calcium ion channels by tricyclic antidepressants – experimental and theoretical justification for their use for neuropathic pain. RSC Medicinal Chemistry, 13 (2), 183-195. doi: 10.1039/d1md00331c

Inhibition of N-type calcium ion channels by tricyclic antidepressants – experimental and theoretical justification for their use for neuropathic pain

2021

Journal Article

Voltage-gated sodium channel modulation by a new spider toxin Ssp1a isolated from an Australian theraphosid

Dongol, Yashad, Choi, Phil M., Wilson, David T., Daly, Norelle L., Cardoso, Fernanda C. and Lewis, Richard J. (2021). Voltage-gated sodium channel modulation by a new spider toxin Ssp1a isolated from an Australian theraphosid. Frontiers in Pharmacology, 12 795455, 795455. doi: 10.3389/fphar.2021.795455

Voltage-gated sodium channel modulation by a new spider toxin Ssp1a isolated from an Australian theraphosid

2021

Journal Article

Engineering of a spider peptide via conserved structure-function traits optimizes sodium channel inhibition in vitro and anti-nociception in vivo

Hu, Huiyu, Mawlawi, Saja, Zhao, Tianjiao, Jami, Sina, Deuis, Jennifer R., Vetter, Irina, Lewis, Richard J. and Cardoso, Fernanda C. (2021). Engineering of a spider peptide via conserved structure-function traits optimizes sodium channel inhibition in vitro and anti-nociception in vivo. Frontiers in Molecular Biosciences, 8 742457, 742457. doi: 10.3389/fmolb.2021.742457

Engineering of a spider peptide via conserved structure-function traits optimizes sodium channel inhibition in vitro and anti-nociception in vivo

2021

Journal Article

Pharmacological Inhibition of the Voltage-Gated Sodium Channel Nav1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome

Jiang, Yan, Castro, Joel, Blomster, Linda V., Agwa, Akello J., Maddern, Jessica, Schober, Gudrun, Herzig, Volker, Chow, Chun Yuen, Cardoso, Fernanda C., Demétrio De Souza França, Paula, Gonzales, Junior, Schroeder, Christina I., Esche, Steffen, Reiner, Thomas, Brierley, Stuart M. and King, Glenn F. (2021). Pharmacological Inhibition of the Voltage-Gated Sodium Channel Nav1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome. ACS Pharmacology & Translational Science, 4 (4) acsptsci.1c00072, 1362-1378. doi: 10.1021/acsptsci.1c00072

Pharmacological Inhibition of the Voltage-Gated Sodium Channel Nav1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome

2021

Conference Publication

Rapid optimization of spider peptides using conserved structure-function traits

Cardoso, Fernanda C. (2021). Rapid optimization of spider peptides using conserved structure-function traits. Venom to Drugs Conference, Daydream Island, QLD Australia, 15-19 March 2021.

Rapid optimization of spider peptides using conserved structure-function traits

2021

Journal Article

Transfection methods for high-throughput cellular assays of voltage-gated calcium and sodium channels involved in pain

Hasan, Md. Mahadhi, Ragnarsson, Lotten, Cardoso, Fernanda C. and Lewis, Richard J. (2021). Transfection methods for high-throughput cellular assays of voltage-gated calcium and sodium channels involved in pain. PLOS ONE, 16 (3) e0243645, e0243645. doi: 10.1371/journal.pone.0243645

Transfection methods for high-throughput cellular assays of voltage-gated calcium and sodium channels involved in pain

2021

Conference Publication

Characterization and structure-function of a novel spider-venom toxin Phlo3a at hNav1.2, 1.3 and 1.7

Dongol, Yashad, Cardoso, Fernanda C. and Lewis, Richard J. (2021). Characterization and structure-function of a novel spider-venom toxin Phlo3a at hNav1.2, 1.3 and 1.7. Venom to Drugs, Daydream Island, QLD, Australia, 15-19 March 2021.

Characterization and structure-function of a novel spider-venom toxin Phlo3a at hNav1.2, 1.3 and 1.7

2021

Conference Publication

Subcutaneous analgesic actions and mode of action of binding of ω-conotoxins at Cav2.2

Hasan, Mahadhi, Abraham, Nikita, Cardoso, Fernanda C., Ragnarsson, Lotten, Starobova, Hana, Mueller, Alexander, Vetter, Irina and Lewis, Richard J. (2021). Subcutaneous analgesic actions and mode of action of binding of ω-conotoxins at Cav2.2. Venom to Drugs, Daydream Island, QLD Australia, 15 - 19 March 2021.

Subcutaneous analgesic actions and mode of action of binding of ω-conotoxins at Cav2.2

2021

Conference Publication

Structure-function of the spider peptide ProTx-III

Zhao, Tianjiao, Rosengren, Johan K., Cardoso, Fernanda C. and Lewis, Richard J. (2021). Structure-function of the spider peptide ProTx-III. Venom to Drugs, Daydream Island, QLD Australia, 15-19 March 2021.

Structure-function of the spider peptide ProTx-III

2021

Journal Article

A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome

Cardoso, Fernanda C., Castro, Joel, Grundy, Luke, Schober, Gudrun, Garcia-Caraballo, Sonia, Zhao, Tianjiao, Herzig, Volker, King, Glenn F., Brierley, Stuart M. and Lewis, Richard J. (2021). A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome. Pain, 162 (2), 569-581. doi: 10.1097/j.pain.0000000000002041

A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome

2020

Conference Publication

Rationally Designed Analogues of the Novel Spider-venom Peptide Phlo3a Shifts the Potency and Subtype Selectivity at Therapeutic Nav Channel Targets for Pain and Epilepsy

Dongol, Y., Choi, P., Wilson, D., Cardoso, F. C. and Lewis, R. J. (2020). Rationally Designed Analogues of the Novel Spider-venom Peptide Phlo3a Shifts the Potency and Subtype Selectivity at Therapeutic Nav Channel Targets for Pain and Epilepsy. SBMS Postgraduate Symposium in Biomedical Sciences, Brisbane, QLD Australia, 24 November 2020.

Rationally Designed Analogues of the Novel Spider-venom Peptide Phlo3a Shifts the Potency and Subtype Selectivity at Therapeutic Nav Channel Targets for Pain and Epilepsy

2020

Journal Article

Two for the price of one: heterobivalent ligand design targeting two binding sites on voltage-gated sodium channels slows ligand dissociation and enhances otency

Peschel, Alicia, Cardoso, Fernanda C., Walker, Andrew A., Durek, Thomas, Stone, M Rhia L., Braga Emidio, Nayara, Dawson, Philip E., Muttenthaler, Markus and King, Glenn F. (2020). Two for the price of one: heterobivalent ligand design targeting two binding sites on voltage-gated sodium channels slows ligand dissociation and enhances otency. Journal of Medicinal Chemistry, 63 (21), 12773-12785. doi: 10.1021/acs.jmedchem.0c01107

Two for the price of one: heterobivalent ligand design targeting two binding sites on voltage-gated sodium channels slows ligand dissociation and enhances otency

2020

Journal Article

The neuronal calcium ion channel activity of constrained analogues of MONIRO-1

Cardoso, Fernanda C., Marliac, Marie-Adeline, Geoffroy, Chloe, Schmit, Matthieu, Bispat, Anjie, Lewis, Richard J., Tuck, Kellie L. and Duggan, Peter J. (2020). The neuronal calcium ion channel activity of constrained analogues of MONIRO-1. Bioorganic and Medicinal Chemistry, 28 (18) 115655, 115655. doi: 10.1016/j.bmc.2020.115655

The neuronal calcium ion channel activity of constrained analogues of MONIRO-1

2020

Journal Article

Characterisation of δ-Conotoxin TxVIA as a mammalian T-type calcium channel modulator

Wang, Dan, Himaya, S.W.A., Giacomotto, Jean, Hasan, Md. Mahadhi, Cardoso, Fernanda C., Ragnarsson, Lotten and Lewis, Richard J. (2020). Characterisation of δ-Conotoxin TxVIA as a mammalian T-type calcium channel modulator. Marine Drugs, 18 (7) 343, 1-13. doi: 10.3390/md18070343

Characterisation of δ-Conotoxin TxVIA as a mammalian T-type calcium channel modulator

2020

Journal Article

Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases

Cardoso, Fernanda C (2020). Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases. Biochemical Pharmacology, 181 114107, 114107. doi: 10.1016/j.bcp.2020.114107

Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases

Funding

Current funding

  • 2023 - 2026
    Peptide Inhibitors Targeting Sodium Channels to Treat Amyotrophic Lateral Sclerosis
    United States Congressionally Directed Medical Research Programs - Amyotrophic Lateral Sclerosis Research Program
    Open grant

Past funding

  • 2020 - 2023
    Novel multifunctional analgesic sodium channel inhibitors
    NHMRC IDEAS Grants
    Open grant
  • 2018 - 2019
    Development of dual Nav1.1/1.7 inhibitors for the treatment of IBS-related pain
    UniQuest Pty Ltd
    Open grant

Supervision

Availability

Dr Fernanda Cardoso is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Selective modulation voltage gated sodium channels to investigate pathophysiology and treatment for motor neuron disease

    Principal Advisor

Completed supervision

Media

Enquiries

Contact Dr Fernanda Cardoso directly for media enquiries about:

  • Analgesics
  • Bio-active peptides
  • Drug discovery
  • Ion channels
  • Irritable bowel syndrome
  • Motor Neuron Disease
  • Neurodegeneration
  • Neurological disorders
  • Pain
  • Snake
  • Spider
  • Toxins
  • Venoms

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au